Sensors having protective eluting coating and method therefor

• US 8,131,364 B2
• Filed: 01/04/2011
• Issued: 03/06/2012
• Est. Priority Date: 09/30/2003
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Zhu, Qingsheng, Heil, Ronald W. Jr., Jain, Mudit
• Primary Examiner(s): Manuel, George
• Assistant Examiner(s): Wieland, Robert N
• Application Number:
  US12/984,161
• Publication Number:
  US 20110098547A1
• Time in Patent Office: 427 Days
• Field of Search: 514/365, 514/772.5, 604/890.1, 604/264, 607/9, 607/22, 424/419, 427/2.1
• US Class Current: 607/22
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61N 1/0568 with drug delivery

Abstract

An apparatus includes an implantable device, such as a chronically implantable device that has a device body. One or more chemical sensors are coupled with the device body. A drug eluting substance is disposed at a location including at least one of on, directly adjacent, or near the one or more chemical sensors, where the drug eluting substance prevents fibrotic growth on the one or more chemical sensors.

Claims

1. A chronically implantable medical device comprising:

a device body;

at least one chemical sensor disposed on the device body, the at least one chemical sensor adapted to monitor a chemical substance present within blood or body tissue; and

a drug eluting coating for preventing fibrous tissue ingrowth disposed on the at least one chemical sensor, the drug eluting coating comprising a drug admixed with a polymeric binder.

2. The chronically implantable medical device according to claim 1, wherein the drug eluting coating comprises a steroid.

3. The chronically implantable medical device according to claim 1, wherein the drug eluting coating comprises dexamethasone.

4. The chronically implantable medical device according to claim 1, wherein the at least one chemical sensor is adapted to monitor one or more chemical substances selected from the group consisting of:

bicarbonate, blood urea nitrogen (BUN), brain naturetic peptide (BNP), calcium, chloride, C-reactive peptide (CRP), creatine phosphokinase (CPK), creatinine, glucose, potassium, renin, and sodium.

5. The chronically implantable medical device according to claim 1, wherein the at least one chemical sensor is adapted to monitor at least one parameter selected from the group consisting of:

osmolarity, pCO₂, pO₂, and pH.

6. The chronically implantable medical device according to claim 1, wherein the at least one chemical sensor is adapted to monitor glucose.

7. The chronically implantable medical device according to claim 1, wherein the at least one chemical sensor is adapted to monitor renin.

8. The chronically implantable medical device according to claim 1, wherein the drug eluting coating comprises a drug selected from the group consisting of bisphosphonates, anti-platelet agents, and fibrinolytic agents.

9. The chronically implantable medical device according to claim 1, wherein the drug eluting coating comprises any one of plasmin, streptokinase, or urokinase.

10. A chronically implantable medical device comprising:

at least one chemical sensor disposed on a medical device body, the at least one chemical sensor adapted to monitor a chemical substance present within blood or body tissue; and

a drug eluting coating for preventing fibrous tissue ingrowth disposed on the at least one chemical sensor, the drug eluting coating comprising a drug admixed with a polymeric binder.

11. The chronically implantable medical device according to claim 10, wherein the drug eluting coating comprises a steroid.

12. The chronically implantable medical device according to claim 10, wherein the drug eluting coating comprises dexamethasone.

13. The chronically implantable medical device according to claim 10, wherein the at least one chemical sensor is adapted to monitor glucose.

14. The chronically implantable medical device according to claim 10, wherein the at least one chemical sensor is adapted to monitor renin.

15. The chronically implantable medical device according to claim 10, wherein the drug eluting coating comprises a drug selected from the group consisting of bisphosphonates, anti-platelet agents, and fibrinolytic agents.

16. A method comprising:

coupling at least one chemical sensor with a medical device body, wherein the at least one chemical sensor is adapted to monitor a chemical substance present within blood or body tissue;

admixing a drug with a polymeric binder to form a drug eluting coating; and

disposing the drug eluting coating on the at least one chemical sensor, wherein the drug eluting coating prevents fibrotic tissue ingrowth on the at least one chemical sensor.

17. The method according to claim 16, further comprising filling a cavity in the medical device body with the drug eluting coating.